Overdue for an Overhaul: How Opioid Treatment Programs Can Learn From COVID-19.
作者信息
Greenblatt Aaron D, Magidson Jessica F, Belcher Annabelle M, Gandhi Devang, Weintraub Eric
机构信息
Division of Addiction Research and Treatment, Department of Psychiatry, University of Maryland School of Medicine, Baltimore; Department of Family & Community Medicine, University of Maryland School of Medicine, Baltimore.
Department of Psychology, University of Maryland, College Park.
出版信息
Mayo Clin Proc. 2020 Oct;95(10):2076-2078. doi: 10.1016/j.mayocp.2020.08.011. Epub 2020 Aug 25.
Abstract
摘要
相似文献
1
Overdue for an Overhaul: How Opioid Treatment Programs Can Learn From COVID-19.亟待全面改革：阿片类药物治疗项目如何从新冠疫情中汲取经验教训
Mayo Clin Proc. 2020 Oct;95(10):2076-2078. doi: 10.1016/j.mayocp.2020.08.011. Epub 2020 Aug 25.
2
TIME TO REVISIT UNEVEN POLICY IN THE UNITED STATES FOR MEDICATION FOR OPIOID USE DISORDER DURING COVID-19.是时候重新审视美国在新冠疫情期间针对阿片类药物使用障碍药物治疗的不均衡政策了。
Addiction. 2020 Oct;115(10):1978-1979. doi: 10.1111/add.15143. Epub 2020 Jul 1.
3
Opioid use disorder and the COVID 19 pandemic: A call to sustain regulatory easements and further expand access to treatment.阿片类药物使用障碍和 COVID-19 大流行：呼吁维持监管放宽，并进一步扩大治疗机会。
Subst Abus. 2020;41(2):147-149. doi: 10.1080/08897077.2020.1752351.
4
An overdose surge will compound the COVID-19 pandemic if urgent action is not taken.如果不采取紧急行动，药物过量潮将使 COVID-19 大流行更加严重。
Nat Med. 2020 Jun;26(6):819-820. doi: 10.1038/s41591-020-0898-0.
5
Opioid Use Disorder Treatment and Potential Interactions With Novel COVID-19 Medications: A Clinical Perspective.阿片类物质使用障碍的治疗及与新型 COVID-19 药物的潜在相互作用：临床视角
Prim Care Companion CNS Disord. 2020 Jul 2;22(4):20com02703. doi: 10.4088/PCC.20com02703.
6
Preparing hospitals for coronavirus (COVID-19).为应对冠状病毒（COVID-19）做好医院准备。
Hosp Pract (1995). 2020 Aug;48(3):121-122. doi: 10.1080/21548331.2020.1757337. Epub 2020 May 12.
7
Coronavirus Disease 2019 (COVID-19) and Immune-Engaging Cancer Treatment.2019冠状病毒病（COVID-19）与免疫参与性癌症治疗
JAMA Oncol. 2020 Oct 1;6(10):1529-1530. doi: 10.1001/jamaoncol.2020.2367.
8
An Epidemic in the Midst of a Pandemic: Opioid Use Disorder and COVID-19.大流行中的疫情：阿片类药物使用障碍和 COVID-19。
Ann Intern Med. 2020 Jul 7;173(1):57-58. doi: 10.7326/M20-1141. Epub 2020 Apr 2.
9
Psoriasis-COVID 19 Infection: Treatment Options.银屑病-新冠病毒感染：治疗选择
Skinmed. 2020 Mar 1;18(2):81-82. eCollection 2020.
10
An Italian programme for COVID-19 infection in multiple sclerosis.一项针对多发性硬化症患者新冠病毒感染情况的意大利项目。
Lancet Neurol. 2020 Jun;19(6):481-482. doi: 10.1016/S1474-4422(20)30147-2. Epub 2020 Apr 30.
引用本文的文献
1
"HEAL together": a randomized, hybrid type 1 effectiveness-implementation trial protocol of a peer-delivered behavioral activation intervention to improve methadone treatment retention.“共同康复”：一项随机、混合型1有效性-实施性试验方案，关于同伴提供的行为激活干预以提高美沙酮治疗留存率
Front Public Health. 2025 Jul 18;13:1637846. doi: 10.3389/fpubh.2025.1637846. eCollection 2025.
2
State guidance and system changes related to COVID-19: Impact on opioid treatment programs.与2019冠状病毒病相关的国家指导方针和系统变化：对阿片类药物治疗项目的影响。
J Subst Use Addict Treat. 2024 Mar;158:209214. doi: 10.1016/j.josat.2023.209214. Epub 2023 Nov 30.
3
"Sign Me Up": a qualitative study of video observed therapy (VOT) for patients receiving expedited methadone take-homes during the COVID-19 pandemic.“Sign Me Up”：一项针对在 COVID-19 大流行期间接受加速美沙酮带回家治疗的患者进行视频观察治疗（VOT）的定性研究。
Addict Sci Clin Pract. 2023 Mar 29;18(1):21. doi: 10.1186/s13722-023-00372-3.
4
Patient experiences of COVID-19-induced changes to methadone treatment in a large community-based opioid treatment program in Baltimore.巴尔的摩一个大型社区为基础的阿片类药物治疗项目中，患者对 COVID-19 导致美沙酮治疗变化的体验。
J Subst Use Addict Treat. 2023 Feb;145:208946. doi: 10.1016/j.josat.2022.208946. Epub 2023 Jan 7.
5
Factors Associated With Increased Opioid Use During the COVID-19 Pandemic: A Prospective Study of Patients Enrolled in Opioid Agonist Treatment.与 COVID-19 大流行期间阿片类药物使用增加相关的因素：一项纳入阿片类药物激动剂治疗患者的前瞻性研究。
J Addict Med. 2022;16(4):e257-e264. doi: 10.1097/ADM.0000000000000939. Epub 2021 Nov 16.
6
Buprenorphine Induction in a Rural Maryland Detention Center During COVID-19: Implementation and Preliminary Outcomes of a Novel Telemedicine Treatment Program for Incarcerated Individuals With Opioid Use Disorder.新冠疫情期间马里兰州农村拘留中心的丁丙诺啡诱导治疗：针对患有阿片类物质使用障碍的被监禁人员的新型远程医疗治疗项目的实施与初步成果
Front Psychiatry. 2021 Oct 28;12:703685. doi: 10.3389/fpsyt.2021.703685. eCollection 2021.
7
COVID-19-related policy changes for methadone take-home dosing: A multistate survey of opioid treatment program leadership.美沙酮口服药物维持治疗点与 COVID-19 相关的政策变化：一项针对阿片类药物治疗项目领导层的多州调查。
Subst Abus. 2022;43(1):633-639. doi: 10.1080/08897077.2021.1986768. Epub 2021 Oct 19.
8
Patient Satisfaction With Medications for Opioid Use Disorder Treatment via Telemedicine: Brief Literature Review and Development of a New Assessment.患者对通过远程医疗治疗阿片类药物使用障碍药物的满意度：简要文献综述及新评估方法的制定。
Front Public Health. 2021 Jan 21;8:557275. doi: 10.3389/fpubh.2020.557275. eCollection 2020.
9
"I have to be around people that are doing what I'm doing": The importance of expanding the peer recovery coach role in treatment of opioid use disorder in the face of COVID-19 health disparities.“我必须和正在做我所做的事情的人在一起”：在 COVID-19 健康差距面前，扩大同伴康复教练在阿片类药物使用障碍治疗中的作用的重要性。
J Subst Abuse Treat. 2021 Mar;122:108182. doi: 10.1016/j.jsat.2020.108182. Epub 2020 Oct 21.
本文引用的文献
1
Opioid agonist treatment and fatal overdose risk in a state-wide US population receiving opioid use disorder services.在美国全州接受阿片类药物使用障碍服务的人群中，阿片类激动剂治疗与致命性药物过量风险的关系。
Addiction. 2020 Sep;115(9):1683-1694. doi: 10.1111/add.14991. Epub 2020 Feb 24.
2
Stigma as a fundamental hindrance to the United States opioid overdose crisis response.污名化是美国阿片类药物过量危机应对的根本障碍。
PLoS Med. 2019 Nov 26;16(11):e1002969. doi: 10.1371/journal.pmed.1002969. eCollection 2019 Nov.
3
Methadone in Primary Care - One Small Step for Congress, One Giant Leap for Addiction Treatment.基层医疗中的美沙酮——对国会来说是一小步，对成瘾治疗来说是一大步。
N Engl J Med. 2018 Jul 5;379(1):7-8. doi: 10.1056/NEJMp1803982.
4
Prohibition of take-home dosages: negative consequences on methadone maintenance treatment.禁止带回家的剂量：对美沙酮维持治疗的负面影响。
Drug Alcohol Depend. 1996 May;41(1):81-4. doi: 10.1016/0376-8716(96)01240-9.
Zotero 插件